PANLI DSR is a dual-action proton pump inhibitor + prokinetic agent used in the management of gastroesophageal reflux disease (GERD), peptic ulcers, and related gastrointestinal disorders. Each delayed-release capsule delivers precise, sustained therapeutic action.
Delayed-release dual-layer capsule technology
Sustained release of Domperidone for prolonged prokinetic action
Enteric-coated Pantoprazole granules for optimal acid suppression
Once-daily dosing for patient compliance
Stable at room temperature
Provides effective relief from acidity and heartburn
